Opdivo, simply nivolumab, represents a groundbreaking advancement in malignancy therapy. It's a class of immunotherapy, specifically a monoclonal antibody, designed to boost your immune system's natural responses combat cancer. Unlike older treatments that kill cancer cells, Opdivo functions by bloc